home
RSS
November 2nd, 2011
05:09 PM ET

New drug 'big deal' in cystic fibrosis fight

A new pill may help in the fight with cystic fibrosis.

A study, funded in part by Vertex Pharmaceuticals, found the drug ivacaftor (pronounced eye va kaf tor) caused patients with a specific type of cystic fibrosis to improve lung function, gain weight, and fight other aspects of the disease.

“This is the first time that we have a therapy that is directed at the cause of cystic fibrosis,” says Dr. Michael Konstan, the chair of the Department of Pediatrics at Rainbow Babies and Children’s Hospital in Cleveland and one of the authors of the study. There is no cure for this disease and existing treatments just help alleviate some of the symptoms.

“This is a big deal,” says Robert Beall, the president and CEO of the Cystic Fibrosis Foundation.  “The fact is it is obviously going to make a very big difference in the lives of patients.”

Cystic fibrosis is a genetic disease that causes problems with the balance of salt going in and out of cells. A sticky mucus clogs organs, particularly the lungs and liver. It can also cause digestive problems. About 1,000 new cases are diagnosed each year, according to the Cystic Fibrosis Foundation, and the average person with the disease dies before age 40.

Ivacaftor works for people with the G551D mutation of cystic fibrosis. Konstan says that only about 4% of the people with the disease have this specific mutation. “It really is a major milestone in the treatment of cystic fibrosis,” he says. “Even thought it only affects a small percentage (of patients) the hope is there that we can finally do something about this disease.”

The study, published in the New England Journal of Medicine Wednesday, looked at 84 people who got the drug. Those taking ivacaftor saw improvements within two weeks, which continued for the nearly yearlong trial. Drug recipients could blow out more than 10% more air from their lungs compared with patients who were not taking the drug, and were about half as likely to have a “pulmonary exacerbation” or a worsening of their lung disease that often requires hospitalization. On average, patients taking the drug grew more and put on more weight than the placebo group, according to the study, and had lower sweat chloride – an indicator of the disease.

Beall says the improved lung function helped patients double their ability to walk and one patient even started going the gym for the first time.

“We have an incredible proof of concept,” Beall says. He points to other research under way with ivacaftor combined with another drug that could help people with the most common mutation of cystic fibrosis. That trial is ongoing and the treatment is at least four or five  years away from approval, but if it works, Beall says, it could help 90% of the people with cystic fibrosis.

In an editorial accompanying the study, Dr. Pamela Davis, of Case Western University paraphrased Winston Churchill, “This study is also a great victory in the war against genetic diseases and marks the end of the beginning for the treatment of the cystic fibrosis defect.”

Ivacaftor has been submitted to the FDA for approval, and could be available next year, according to Konstan. When it goes on sale it will be sold under the brand name Kalydeco (pronounced kuh-LYE-deh-koh).


soundoff (125 Responses)
  1. LabxEncox

    cialis price at walgreens cialis doppelte menge l arginina e cialis

    February 16, 2021 at 12:41 | Report abuse | Reply
  2. silly-colden-0637ea.netlify.app

    Jkbose 10th Result 2019 Ladakh Crc Handbook Of Chemistry
    And Physics Amazon

    My web page :: pdf book (silly-colden-0637ea.netlify.app)

    February 17, 2021 at 12:20 | Report abuse | Reply
  3. FbsgZisse

    online cialis florida delivery http://llecialisjaw.com/ cialis usa

    February 18, 2021 at 21:35 | Report abuse | Reply
  4. zithromax 500

    azithromycin and zithromax zithromax 250 mg zithromax 500mg

    February 20, 2021 at 15:58 | Report abuse | Reply
  5. NbmoZisse

    buy cialis 20mg http://buycialisxz.com/ cialis 10 mg

    February 27, 2021 at 10:45 | Report abuse | Reply
  6. ClarkTauts

    ocgw5 p90ne nrzj

    March 1, 2021 at 12:30 | Report abuse | Reply
  7. KndnMile

    viagra cvs viagra online canada viagra pills

    March 2, 2021 at 07:39 | Report abuse | Reply
  8. Michael Bartleson

    Greetings I am so glad I found your blog page, I really found you by mistake, while I was looking on Yahoo for something else, Anyways I am here now and would just like to say thank you for a remarkable post and a all round enjoyable blog (I also love the theme/design), I don’t have time to read it all at the minute but I have book-marked it and also added your RSS feeds, so when I have time I will be back to read more, Please do keep up the superb work.

    https://proxyti.com/buy/200-private-proxies

    March 2, 2021 at 16:06 | Report abuse | Reply
1 2 3

Leave a Reply to JvcbxCrulk


 

CNN welcomes a lively and courteous discussion as long as you follow the Rules of Conduct set forth in our Terms of Service. Comments are not pre-screened before they post. You agree that anything you post may be used, along with your name and profile picture, in accordance with our Privacy Policy and the license you have granted pursuant to our Terms of Service.

Advertisement
About this blog

Get a behind-the-scenes look at the latest stories from CNN Chief Medical Correspondent, Dr. Sanjay Gupta, Senior Medical Correspondent Elizabeth Cohen and the CNN Medical Unit producers. They'll share news and views on health and medical trends - info that will help you take better care of yourself and the people you love.